Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Environ Int. 2016 Apr 22;92-93:220–231. doi: 10.1016/j.envint.2016.03.033

Table 5c.

Association between internal dose of THMs (within the fourth quartile in comparison to the first three quartiles) and SGA for newborns and mothers GSTT1 or GSTM1 deletion status

Gene/deletion Cases Controls CHCL3a THMBra TTHMa

n n Adjusted ORb (95% CI) p interaction Adjusted ORb (95% CI) p interaction Adjusted ORb (95% CI) p interaction

Newborns
GSTT1
 No or single deletion 198 793 1.1 (0.7 – 1.7) 0.61 0.9 (0.6 – 1.4) 0.86 1.1 (0.7 – 1.6) 0.44
 Double deletion 73 300 1.4 (0.7 – 2.7) 1.0 (0.5 – 2.0) 1.4 (0.7 – 2.7)
GSTM1
 No or single deletion 112 491 1.4 (0.8 – 2.4) 0.96 1.1 (0.6 – 1.8) 0.67 1.4 (0.8 – 2.4) 0.95
 Double deletion 159 602 1.4 (0.7 – 2.8) 1.2 (0.6 – 2.4) 1.4 (0.7 – 2.8)
Mothers
GSTT1
 No or single deletion 59 228 1.1 (0.7 – 1.7) 0.48 0.9 (0.6 – 1.4) 0.65 1.1 (0.7 – 1.4) 0.18
 Double deletion 212 865 1.5 (0.7 – 3.2) 1.1 (0.5 – 2.3) 1.8 (0.9 – 2.3)
GSTM1
 No or single deletion 146 610 1.4 (0.8 – 2.4) 0.67 1.1 (0.6 – 1.8) 0.38 1.4 (0.8 – 1.8) 0.64
 Double deletion 125 483 1.2 (0.6 – 2.4) 0.8 (0.4 – 1.6) 1.2 (0.6 – 1.6)
a

CHCl3=Chloroform, THMBr= Brominated THM, TTHM= Total Trihalomethanes

b

OR adjusted for the following variables: maternal age, maternal education, annual household income, prepregnancy BMI, parity, history of chronic disease, preeclampsia, active smoking during the third trimester, passive smoking throughout pregnancy, coffee and alcohol consumption during pregnancy and month of selection.